search
Back to results

Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders (ENHANCE)

Primary Purpose

Delirium, Neurocognitive Disorders, Mild Cognitive Impairment

Status
Not yet recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
HELP
FAM-HELP
Sponsored by
University of Michigan
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Delirium focused on measuring Delirium, Clinical Trial, Comparative Effectiveness Research, Implementation Science

Eligibility Criteria

70 Years - undefined (Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Provision of informed consent At least 70 years of age Anticipated length of hospital stay at least 72 hours Family member or care partner available to be on-site in the hospital At least one delirium risk factor (e.g., cognitive or functional impairment, dehydration, vision or hearing impairment) Exclusion Criteria: Delirium on admission Unable to communicate verbally (e.g., coma, mechanical ventilation) Unable to participate fully in interventions (e.g., terminal condition, advanced dementia) Staff safety concerns (e.g., violent behavior) Cardiac or intracranial surgery (due to competing causes of delirium)

Sites / Locations

  • Saddleback Medical Center
  • MaineHealth
  • Michigan Medicine
  • Hospital of the University of Pennsylvania
  • Allegheny General Hospital
  • University of Utah
  • Meriter Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Hospital Elder Life Program (HELP)

Family-Augmented Hospital Elder Life Program (FAM-HELP)

Arm Description

Hospital Elder Life Program (HELP) is built upon multicomponent, non-pharmacologic strategies that target delirium risk factors to optimize cognitive and clinical function during hospitalization.

The FAM-HELP program will incorporate a family member and/or care partner, who will play a central role with providing bedside support for delirium risk reduction. Family members and care partners will provide social and emotional support along with augmentation of HELP-based protocols.

Outcomes

Primary Outcome Measures

Delirium Incidence
Any positive delirium screen (yes/no) as determined by the long-form Confusion Assessment Method (CAM)
Delirium Severity
Delirium severity score will be recorded using the Confusion Assessment Method Long Form Severity Score (CAM-S) (n, 0-19, with higher number indicating more severe delirium)

Secondary Outcome Measures

Delirium Duration
The cumulative number of days (n) with a positive delirium screen will be calculated for all participants
Persistent Delirium
Positive delirium screen (yes/no) 30 days after hospital discharge as determined by the long-form Confusion Assessment Method (AM)
Delirium Burden - Patient
Delirium burden will be calculated using the Patient Delirium Burden Scale (DEL-B-P) (n, 0-40, with higher number indicating more severe burden)
Delirium Burden - Family and Care Partners
Delirium burden will be calculated using the Patient Delirium Family Caregiver Scale (DEL-B-C) (n, 0-40, with higher number indicating more severe burden)
Caregiving Strain
Strain associated with patient caregiving will be assessed via Modified Caregiver Strain Index (MCSI) (n, 0-26, with higher number indicating more caregiver strain)
Cognitive Function - Subjective Reporting
Subjective reporting of cognitive function will be assessed via PROMIS Cognitive Function - Short Form 6a (n, 6-30, with higher number indicating better subjective cognitive function)
Hospital Experience
Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) Survey (n, 7-28, with higher score indicating better hospital experience)
Global Health
Assessment of overall physical and mental health via PROMIS Global Health-10. Two separate subscales will be calculated, Global Physical Health (n, 4-20) and Global Mental Health (n, 4-20), with higher scores indicating better health.
Physical Function
Assessment of physical function via PROMIS Physical Short Form 10a (n, 10-50, with higher scores indicating better physical function).
Falls
Proportion of participants in each group (%) experiencing at least one fall
Length of Hospital Stay
Total number of days (n) spent in the hospital
Discharge Disposition
Proportion of patients in each group (%) discharged somewhere other than home (e.g., Long-Term Care Facility)
30-Day Readmission
Proportion of participants in each group (%) requiring hospital readmission

Full Information

First Posted
June 20, 2023
Last Updated
October 4, 2023
Sponsor
University of Michigan
Collaborators
Hebrew SeniorLife, MaineHealth, University of Pennsylvania, West Penn Allegheny Health System, UnityPoint Health - Meriter Hospital, University of Utah, MemorialCare Saddleback Medical Center, Brandeis University, Indiana University, Patient-Centered Outcomes Research Institute
search

1. Study Identification

Unique Protocol Identification Number
NCT05929703
Brief Title
Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders
Acronym
ENHANCE
Official Title
Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders (ENHANCE)
Study Type
Interventional

2. Study Status

Record Verification Date
October 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
October 2023 (Anticipated)
Primary Completion Date
May 2027 (Anticipated)
Study Completion Date
August 2027 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Michigan
Collaborators
Hebrew SeniorLife, MaineHealth, University of Pennsylvania, West Penn Allegheny Health System, UnityPoint Health - Meriter Hospital, University of Utah, MemorialCare Saddleback Medical Center, Brandeis University, Indiana University, Patient-Centered Outcomes Research Institute

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The goal of this clinical trial is to compare the Hospital Elder Life Program (HELP) with a family-augmented version of HELP (FAM-HELP), that includes family members and care partners, for the prevention of delirium in older patients during hospital admission. The main objectives of the trial are the following: To compare the effectiveness of FAM-HELP and HELP in reducing both the incidence of delirium and its severity. To compare the effectiveness of FAM-HELP and HELP in improving patient- and family-reported outcomes. To explore the implementation context, process, and outcomes of the FAM-HELP program in diverse hospital settings.
Detailed Description
Delirium is a common complication of hospitalization and major surgery for older adults, and it can lead to loss of independence and substantial healthcare costs. One approach to preventing delirium is through the Hospital Elder Life Program (HELP). HELP personnel work to prevent delirium by providing orienting communication, assisting patients with walking and exercise, providing help with nutrition and fluids, implementing sleep protocols, and helping patients with vision and hearing aids. However, it is unknown whether involving family members in these activities along with HELP staff (i.e., "FAM-HELP") might be more effective with preventing delirium. The objective of this clinical trial is thus to compare the traditional HELP program with a family-augmented version of HELP (FAM-HELP) to determine which program is more effective with preventing delirium and related complications in older, hospitalized patients.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Delirium, Neurocognitive Disorders, Mild Cognitive Impairment, Alzheimer Disease, Aging, Family Support, Family Members, Caregiver Burden, Implementation Science, Patient Satisfaction
Keywords
Delirium, Clinical Trial, Comparative Effectiveness Research, Implementation Science

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Stepped-wedge, cluster randomized
Masking
InvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
3000 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Hospital Elder Life Program (HELP)
Arm Type
Active Comparator
Arm Description
Hospital Elder Life Program (HELP) is built upon multicomponent, non-pharmacologic strategies that target delirium risk factors to optimize cognitive and clinical function during hospitalization.
Arm Title
Family-Augmented Hospital Elder Life Program (FAM-HELP)
Arm Type
Active Comparator
Arm Description
The FAM-HELP program will incorporate a family member and/or care partner, who will play a central role with providing bedside support for delirium risk reduction. Family members and care partners will provide social and emotional support along with augmentation of HELP-based protocols.
Intervention Type
Behavioral
Intervention Name(s)
HELP
Intervention Description
This is usual (standard) care across hospitals in this trial. A multidisciplinary team of nurse specialists, social workers, and volunteers implement daily protocols focused on orientation, cognitive stimulation, early mobilization, sleep enhancement, support with visual and hearing aids, mealtime assistance, hydration, reduction in polypharmacy, and nursing-based delirium prevention protocols.
Intervention Type
Behavioral
Intervention Name(s)
FAM-HELP
Intervention Description
Family members and care partners will provide daily emotional and social support during hospitalization. Additionally, family members and care partners will engage in HELP-based protocols throughout the day. The rationale for this protocol augmentation is two-fold: (1) HELP may not consistently have available volunteers (e.g., short-staffing) during a hospital stay, and (2) patients may be more likely to engage in therapeutic activities with a family member given the connection and comfort level.
Primary Outcome Measure Information:
Title
Delirium Incidence
Description
Any positive delirium screen (yes/no) as determined by the long-form Confusion Assessment Method (CAM)
Time Frame
Day of trial enrollment through day of hospital discharge, up to 14 days
Title
Delirium Severity
Description
Delirium severity score will be recorded using the Confusion Assessment Method Long Form Severity Score (CAM-S) (n, 0-19, with higher number indicating more severe delirium)
Time Frame
Day of trial enrollment through day of hospital discharge, up to 14 days
Secondary Outcome Measure Information:
Title
Delirium Duration
Description
The cumulative number of days (n) with a positive delirium screen will be calculated for all participants
Time Frame
Day of trial enrollment through day of hospital discharge, up to 14 days
Title
Persistent Delirium
Description
Positive delirium screen (yes/no) 30 days after hospital discharge as determined by the long-form Confusion Assessment Method (AM)
Time Frame
30 days after hospital discharge
Title
Delirium Burden - Patient
Description
Delirium burden will be calculated using the Patient Delirium Burden Scale (DEL-B-P) (n, 0-40, with higher number indicating more severe burden)
Time Frame
Day of trial enrollment through 30 days after discharge
Title
Delirium Burden - Family and Care Partners
Description
Delirium burden will be calculated using the Patient Delirium Family Caregiver Scale (DEL-B-C) (n, 0-40, with higher number indicating more severe burden)
Time Frame
Day of trial enrollment through 30 days after discharge
Title
Caregiving Strain
Description
Strain associated with patient caregiving will be assessed via Modified Caregiver Strain Index (MCSI) (n, 0-26, with higher number indicating more caregiver strain)
Time Frame
Hospital discharge through 30 days after discharge
Title
Cognitive Function - Subjective Reporting
Description
Subjective reporting of cognitive function will be assessed via PROMIS Cognitive Function - Short Form 6a (n, 6-30, with higher number indicating better subjective cognitive function)
Time Frame
Hospital discharge through 30 days after discharge
Title
Hospital Experience
Description
Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) Survey (n, 7-28, with higher score indicating better hospital experience)
Time Frame
Day of hospital discharge (typically up to 30 days after hospital admission, may extend to 60 or more days)
Title
Global Health
Description
Assessment of overall physical and mental health via PROMIS Global Health-10. Two separate subscales will be calculated, Global Physical Health (n, 4-20) and Global Mental Health (n, 4-20), with higher scores indicating better health.
Time Frame
Hospital discharge through 30 days after discharge
Title
Physical Function
Description
Assessment of physical function via PROMIS Physical Short Form 10a (n, 10-50, with higher scores indicating better physical function).
Time Frame
30 days after hospital discharge
Title
Falls
Description
Proportion of participants in each group (%) experiencing at least one fall
Time Frame
Day of trial enrollment through 30 days after hospital discharge
Title
Length of Hospital Stay
Description
Total number of days (n) spent in the hospital
Time Frame
Day of hospital admission through hospital discharge (typically up to 30 days after hospital admission, may extend to 60 or more days)
Title
Discharge Disposition
Description
Proportion of patients in each group (%) discharged somewhere other than home (e.g., Long-Term Care Facility)
Time Frame
Day of hospital discharge through 30 days after discharge
Title
30-Day Readmission
Description
Proportion of participants in each group (%) requiring hospital readmission
Time Frame
Day of hospital discharge through 30 days after discharge
Other Pre-specified Outcome Measures:
Title
Antipsychotic use
Description
Proportion of participants in each group (%) requiring antipsychotic medications during hospitalization
Time Frame
Day of trial enrollment through day of hospital discharge, up to 14 days
Title
Restraint use
Description
Proportion of participants in each group (%) requiring restraint use during hospitalization
Time Frame
Day of trial enrollment through day of hospital discharge, up to 14 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Provision of informed consent At least 70 years of age Anticipated length of hospital stay at least 72 hours Family member or care partner available to be on-site in the hospital At least one delirium risk factor (e.g., cognitive or functional impairment, dehydration, vision or hearing impairment) Exclusion Criteria: Delirium on admission Unable to communicate verbally (e.g., coma, mechanical ventilation) Unable to participate fully in interventions (e.g., terminal condition, advanced dementia) Staff safety concerns (e.g., violent behavior) Cardiac or intracranial surgery (due to competing causes of delirium)
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Eva Schmitt, PhD
Phone
617-971-5390
Email
EvaSchmitt@hsl.harvard.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Sharon K Inouye, MD
Organizational Affiliation
Hebrew SeniorLife
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Phillip E Vlisides, MD
Organizational Affiliation
University of Michigan
Official's Role
Principal Investigator
Facility Information:
Facility Name
Saddleback Medical Center
City
Orange
State/Province
California
ZIP/Postal Code
92868
Country
United States
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jessica Dela Rosa, MSN, MBA
Phone
949-607-6030
Email
jdelarosa2@memorialcare.org
Facility Name
MaineHealth
City
Portland
State/Province
Maine
ZIP/Postal Code
04102
Country
United States
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Emily Carter, MD
Phone
207-662-3157
Email
Emily.Carter1@mainehealth.org
Facility Name
Michigan Medicine
City
Ann Arbor
State/Province
Michigan
ZIP/Postal Code
48109
Country
United States
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jocelyn Wiggins, MD
Phone
734-647-7299
Email
wiggi@med.umich.edu
First Name & Middle Initial & Last Name & Degree
Shenbagam Dewar, MBBS
Phone
734-647-7299
Email
sdewar@med.umich.edu
Facility Name
Hospital of the University of Pennsylvania
City
Philadelphia
State/Province
Pennsylvania
ZIP/Postal Code
19104
Country
United States
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Rebecca Trotta, PhD
Phone
215-615-4925
Email
Rebecca.Trotta@pennmedicine.upenn.edu
Facility Name
Allegheny General Hospital
City
Pittsburgh
State/Province
Pennsylvania
ZIP/Postal Code
15212
Country
United States
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Lyn Weinberg, MD
Phone
412-235-5810
Email
Lyn.WEINBERG@ahn.org
Facility Name
University of Utah
City
Salt Lake City
State/Province
Utah
ZIP/Postal Code
84132
Country
United States
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Mark Supiano, MD
Phone
801-587-9103
Email
mark.supiano@utah.edu
Facility Name
Meriter Hospital
City
Madison
State/Province
Wisconsin
ZIP/Postal Code
53715
Country
United States
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Carrie Bennett, DNP
Phone
608-417-5724
Email
carrie.bennett@unitypoint.org

12. IPD Sharing Statement

Learn more about this trial

Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders

We'll reach out to this number within 24 hrs